ATE389636T1 - Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung - Google Patents

Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung

Info

Publication number: ATE389636T1
Authority: AT; Austria
Prior art keywords: substituted pyridine; diseases; compounds; pharmaceutical use; maladies
Prior art date: 1997-12-19

Application number

AT98965447T

Other languages

English (en)

Inventor

Nathan Mantlo

Chan Hwang

Ulrike Spohr

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-19

Filing date

1998-12-21

Publication date

2008-04-15

1998-12-18 Priority claimed from US09/215,426 external-priority patent/US6174901B1/en

1998-12-21 Application filed by Amgen Inc filed Critical Amgen Inc

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE389636T1 publication Critical patent/ATE389636T1/de

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title abstract 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title abstract 2
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical class C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 title 1
201000010099 disease Diseases 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
238000000034 method Methods 0.000 abstract 3
206010028980 Neoplasm Diseases 0.000 abstract 2
208000002193 Pain Diseases 0.000 abstract 2
201000011510 cancer Diseases 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
206010012601 diabetes mellitus Diseases 0.000 abstract 2
238000011321 prophylaxis Methods 0.000 abstract 2
238000011282 treatment Methods 0.000 abstract 2
GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
102000003777 Interleukin-1 beta Human genes 0.000 abstract 1
108090000193 Interleukin-1 beta Proteins 0.000 abstract 1
108090001005 Interleukin-6 Proteins 0.000 abstract 1
102000004890 Interleukin-8 Human genes 0.000 abstract 1
108090001007 Interleukin-8 Proteins 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
150000004892 pyridazines Chemical class 0.000 abstract 1
150000003222 pyridines Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

AT98965447T 1997-12-19 1998-12-21 Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung ATE389636T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6819997P	1997-12-19	1997-12-19
US09/215,426 US6174901B1 (en)	1998-12-18	1998-12-18	Substituted pyridine and pyridazine compounds and methods of use

Publications (1)

Publication Number	Publication Date
ATE389636T1 true ATE389636T1 (de)	2008-04-15

Family

ID=26748691

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98965447T ATE389636T1 (de)	1997-12-19	1998-12-21	Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung

Country Status (15)

Country	Link
EP (1)	EP1042293B9 (de)
JP (1)	JP2001526263A (de)
KR (1)	KR20010033241A (de)
CN (1)	CN1284945A (de)
AT (1)	ATE389636T1 (de)
AU (1)	AU755421B2 (de)
CA (1)	CA2315827C (de)
DE (1)	DE69839278T2 (de)
DK (1)	DK1042293T3 (de)
ES (1)	ES2304797T3 (de)
HU (1)	HUP0101099A3 (de)
IL (1)	IL136711A0 (de)
PT (1)	PT1042293E (de)
SI (1)	SI1042293T1 (de)
WO (1)	WO1999032448A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6350744B1 (en) *	1998-11-20	2002-02-26	Merck & Co., Inc.	Compounds having cytokine inhibitory activity
JP2002534385A (ja)	1999-01-08	2002-10-15	スミスクライン・ビーチャム・コーポレイション	新規化合物
US6602872B1 (en) *	1999-12-13	2003-08-05	Merck & Co., Inc.	Substituted pyridazines having cytokine inhibitory activity
WO2001045716A1 (en) *	1999-12-20	2001-06-28	Gho'st Holding B.V.	Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor
PL207853B1 (pl) *	2000-04-04	2011-02-28	Fundacja Rozwoju Diagnostyki I Terapii	Nowe (1-adamantyloamino)pirydyny, sposób ich wytwarzania i zastosowanie medyczne
US6562807B2 (en)	2000-06-23	2003-05-13	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
US6664256B1 (en) *	2000-07-10	2003-12-16	Kowa Co., Ltd.	Phenylpyridazine compounds and medicines containing the same
US6706744B2 (en)	2000-11-17	2004-03-16	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
US6821960B2 (en)	2000-11-17	2004-11-23	Noyo Nordisk Pharmaceuticals, Inc.	Glucagon antagonists/inverse agonists
JP2004513935A (ja)	2000-11-17	2004-05-13	ノボ　ノルディスク　アクティーゼルスカブ	グルカゴンアンタゴニスト／逆アゴニスト
HUP0500543A2 (hu) *	2000-11-20	2005-09-28	Bristol-Myers Squibb Company	Piridonszármazékok mint aP2 inhibitorok és a vegyületeket tartalmazó gyógyszerkészítmények
US6919323B2 (en)	2001-07-13	2005-07-19	Bristol-Myers Squibb Company	Pyridazinone inhibitors of fatty acid binding protein and method
US6762318B2 (en)	2001-12-03	2004-07-13	Novo Nordisk A/S	Glucagon antagonists
US6881746B2 (en)	2001-12-03	2005-04-19	Novo Nordick A/S	Glucagon antagonists/inverse agonists
US7196106B2 (en)	2002-11-05	2007-03-27	Merck & Co., Inc	Cyanothiophene derivatives, compositions containing such compounds and methods of use
SE0203654D0 (sv) *	2002-12-09	2002-12-09	Astrazeneca Ab	New compounds
US7572922B2 (en)	2003-01-27	2009-08-11	Merck & Co., Inc.	Substituted pyrazoles, compositions containing such compounds and methods of use
EP1650195A4 (de) *	2003-07-30	2008-09-17	Kowa Co	Verfahren zur inhibierung der produktion von osteopontin
US7301036B2 (en)	2003-12-19	2007-11-27	Merck & Co., Inc.	Cyclic guanidines, compositions containing such compounds and methods of use
ES2241496B1 (es) *	2004-04-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos derivados de piridina.
CN1964947A (zh)	2004-06-04	2007-05-16	默克公司	吡唑衍生物、包含其的组合物及其用法
CN101146762A (zh)	2005-03-21	2008-03-19	默克公司	取代的芳基和杂芳基衍生物
WO2006104826A2 (en)	2005-03-30	2006-10-05	Merck & Co., Inc.	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
MX2007014114A (es)	2005-05-10	2008-03-14	Intermune Inc	Derivados de piridona para modular el sistema de proteina cinasa activada por estres.
WO2007015999A2 (en)	2005-07-26	2007-02-08	Merck & Co., Inc.	Process for synthesizing a substituted pyrazole
ES2270715B1 (es)	2005-07-29	2008-04-01	Laboratorios Almirall S.A.	Nuevos derivados de pirazina.
ES2274712B1 (es)	2005-10-06	2008-03-01	Laboratorios Almirall S.A.	Nuevos derivados imidazopiridina.
TW200745031A (en)	2005-10-13	2007-12-16	Merck & Co Inc	Acyl indoles, compositions containing such compounds and methods of use
TWI417095B (zh)	2006-03-15	2013-12-01	Janssen Pharmaceuticals Inc	１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
EP2001472A2 (de)	2006-03-23	2008-12-17	Merck and Co., Inc.	Glucagon-rezeptor-antagonisten-verbindungen, zusammensetzungen mit solchen verbindungen und verfahren zu ihrer verwendung
JP2009537525A (ja)	2006-05-16	2009-10-29	メルクエンドカムパニーインコーポレーテッド	グルカゴン受容体アンタゴニスト化合物、このような化合物を含む組成物及び使用方法
TW200821284A (en)	2006-10-03	2008-05-16	Merck & Co Inc	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
CA2696948C (en)	2007-09-14	2013-04-30	Jose Maria Cid-Nunez	1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
JP5627574B2 (ja)	2008-06-03	2014-11-19	インターミューン，インコーポレイテッド	炎症性および線維性疾患を治療するための化合物および方法
CA2735764C (en)	2008-09-02	2016-06-14	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
BRPI0921333A2 (pt)	2008-11-28	2015-12-29	Addex Pharmaceuticals Sa	derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
NZ596078A (en)	2009-05-12	2013-06-28	Janssen Pharmaceuticals Inc	1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
EA020671B1 (ru)	2009-05-12	2014-12-30	Янссен Фармасьютикалз, Инк.	ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2643320B1 (de)	2010-11-08	2015-03-04	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridinderivate und ihre verwendung als positiv allosterische modulatoren des mglur2 receptors
CA2815002C (en)	2010-11-08	2019-10-22	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298810B (zh)	2010-11-08	2016-03-16	杨森制药公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
MX2013006768A (es)	2010-12-23	2013-07-22	Pfizer	Moduladores de receptor de glucagon.
ES2597972T3 (es)	2011-02-08	2017-01-24	Pfizer Inc	Modulador del receptor de glucagón
RU2013157388A (ru)	2011-07-22	2015-08-27	Пфайзер Инк.	Хинолинильные модуляторы глюкагонового рецептора
AR092742A1 (es)	2012-10-02	2015-04-29	Intermune Inc	Piridinonas antifibroticas
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
EP3065736B1 (de)	2013-11-04	2018-11-14	Merck Sharp & Dohme Corp.	Glucagon-rezeptor-antagonist-verbindungen, zusammensetzungen daraus und verfahren zur verwendung
KR102414246B1 (ko)	2014-01-21	2022-06-27	얀센 파마슈티카 엔.브이.	대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
LT3431106T (lt)	2014-01-21	2021-02-10	Janssen Pharmaceutica Nv	Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
US10233195B2 (en)	2014-04-02	2019-03-19	Intermune, Inc.	Anti-fibrotic pyridinones
CN109311859B (zh) *	2016-04-14	2022-01-21	广州嘉越医药科技有限公司	用于治疗纤维化和炎性疾病的含杂原子环丁烷取代基的吡啶酮衍生物
AU2018334290A1 (en)	2017-09-18	2020-04-02	Goldfinch Bio, Inc.	Pyridazinones and methods of use thereof
WO2021122645A1 (en)	2019-12-20	2021-06-24	Syngenta Crop Protection Ag	Pesticidally active azole-amide compounds
CA3209491A1 (en)	2021-03-15	2022-09-22	Saul Yedgar	Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL6816241A (de) *	1967-12-01	1969-06-03
JPH01258671A (ja) *	1987-12-01	1989-10-16	Morishita Pharmaceut Co Ltd	５−（１ｈ−イミダゾール−１−イル）−３（２ｈ）−ピリダジノン誘導体
US5461053A (en) *	1989-02-07	1995-10-24	Sanofi	Pyridazine derivatives
FR2663326B2 (fr) *	1989-11-17	1992-10-16	Sanofi Sa	Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
JPH06501926A (ja) *	1990-08-06	1994-03-03	藤沢薬品工業株式会社	複素環式化合物
US5686470A (en) *	1995-02-10	1997-11-11	Weier; Richard M.	2, 3-substituted pyridines for the treatment of inflammation
DE69627006T2 (de) *	1995-08-10	2004-01-15	Merck & Co Inc	2-substituierte aryl-pyrrolen, zusammensetzungen solche verbindungen enthaltend und deren verwendung
AU699148B2 (en) *	1995-08-10	1998-11-26	Merck & Co., Inc.	2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
EP1266889A3 (de) *	1996-07-18	2003-12-03	Ciba SC Holding AG	Polyoxyalkylen substituierte und verbrückte Triazin- und Benzotriazol-derivate
CA2412968C (en) *	1996-07-18	2010-05-11	Merck Frosst Canada & Co.	Substituted pyridines as selective cyclooxygenase-2 inhibitors
JP3335132B2 (ja) *	1997-11-19	2002-10-15	興和株式会社	新規ピリダジン誘導体及びこれを有効成分とする医薬

1998
- 1998-12-21 DE DE69839278T patent/DE69839278T2/de not_active Expired - Fee Related
- 1998-12-21 AT AT98965447T patent/ATE389636T1/de not_active IP Right Cessation
- 1998-12-21 WO PCT/US1998/027298 patent/WO1999032448A1/en not_active Ceased
- 1998-12-21 SI SI9830907T patent/SI1042293T1/sl unknown
- 1998-12-21 KR KR1020007006660A patent/KR20010033241A/ko not_active Ceased
- 1998-12-21 CA CA002315827A patent/CA2315827C/en not_active Expired - Fee Related
- 1998-12-21 DK DK98965447T patent/DK1042293T3/da active
- 1998-12-21 HU HU0101099A patent/HUP0101099A3/hu unknown
- 1998-12-21 AU AU20911/99A patent/AU755421B2/en not_active Ceased
- 1998-12-21 JP JP2000525385A patent/JP2001526263A/ja active Pending
- 1998-12-21 PT PT98965447T patent/PT1042293E/pt unknown
- 1998-12-21 IL IL13671198A patent/IL136711A0/xx unknown
- 1998-12-21 CN CN98813653A patent/CN1284945A/zh active Pending
- 1998-12-21 ES ES98965447T patent/ES2304797T3/es not_active Expired - Lifetime
- 1998-12-21 EP EP98965447A patent/EP1042293B9/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SI1042293T1 (sl)	2008-08-31
DE69839278D1 (de)	2008-04-30
WO1999032448A8 (en)	2001-04-19
PT1042293E (pt)	2008-04-18
EP1042293B9 (de)	2008-09-03
HUP0101099A2 (hu)	2001-10-28
EP1042293B1 (de)	2008-03-19
ES2304797T3 (es)	2008-10-16
WO1999032448A1 (en)	1999-07-01
DE69839278T2 (de)	2008-09-11
CA2315827A1 (en)	1999-07-01
IL136711A0 (en)	2001-06-14
CA2315827C (en)	2007-08-21
DK1042293T3 (da)	2008-07-14
KR20010033241A (ko)	2001-04-25
AU2091199A (en)	1999-07-12
CN1284945A (zh)	2001-02-21
AU755421B2 (en)	2002-12-12
EP1042293A1 (de)	2000-10-11
HUP0101099A3 (en)	2002-09-30
JP2001526263A (ja)	2001-12-18

Legal Events

Date

Code

Title

Description

2008-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1042293

Country of ref document: EP

2010-09-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69839278D1 (de)	2008-04-30	Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung
ATE366722T1 (de)	2007-08-15	Substituierte pyridin-derivate als entzündungshemmende mittel
ATE323705T1 (de)	2006-05-15	Substituierte indolizinähnliche verbindungen und ihre verwendung
WO1998024782A3 (en)	1998-08-27	Substituted pyrimidine compounds and their use
ATE320426T1 (de)	2006-04-15	Harnstoffderivate und ihre verwendung
PT948495E (pt)	2004-08-31	Agentes anti-inflamatorios de pirrolo fundido substituidos em arilo e heteroarilo
WO1998024780A3 (en)	1998-07-30	Substituted pyrimidinone and pyridinone compounds and their use
FI20115753L (fi)	2011-07-15	Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
EE200300324A (et)	2003-12-15	Asendatud alküülamiini derivaadid ja nende kasutamismeetodid
IS8175A (is)	2005-12-12	Píperasín afleiður og aðferðir við notkun þeirra
CA2260016A1 (en)	1998-01-29	Substituted pyridines as selective cyclooxygenase-2 inhibitors
EA200401319A1 (ru)	2005-04-28	Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине
ATE271861T1 (de)	2004-08-15	Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
CA2274063A1 (en)	1998-06-11	Substituted pyrimidine compounds and their use
WO2006041888A3 (en)	2007-09-07	Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
EP1314732A3 (de)	2004-01-02	Substituierte Pyrimidinverbindungen und ihre Verwendung
DE60312154D1 (de)	2007-04-12	2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten